90% of pre-revenue founders walk into investor meetings with a valuation they invented on a napkin. VCs use five specific methods to price a company with zero revenue — and the one that wins for AI startups is not the one most founders expect.
Hayat Amin argues that pre-revenue startup valuation is the single highest-leverage skill a founder can learn before raising. "If you let the investor set the price, you will always leave equity on the table," Amin says. "The founders who command the best terms understand the exact framework being used against them — and they show up with IP that moves the needle inside that framework."
Companies with patents are 10.2x more likely to secure early-stage funding. That statistic reshapes every pre-revenue startup valuation conversation. Investors are not guessing. They are running a systematic scoring model, and the variable that swings the output hardest is defensibility — not traction, not TAM slides, not the pitch deck. This post breaks down all five methods, shows which one dominates for AI and IP-heavy companies, and explains how to position your startup to win the highest possible valuation before you generate a single dollar of revenue.
What Are the 5 Pre-Revenue Startup Valuation Methods?
Pre-revenue startup valuation relies on five established methods: Berkus, Scorecard, Risk-Factor Summation, Venture Capital Method, and Cost-to-Duplicate. Each method prices a company with zero revenue by assigning value to the assets, risks, and potential that revenue-based multiples cannot capture. The right method depends on your company type, stage, and the investor sitting across the table.
1. The Berkus Method
Dave Berkus's framework assigns up to $500K for each of five risk-reduction milestones: sound idea, working prototype, quality management team, strategic relationships, and product rollout or sales. Maximum pre-money valuation: $2.5M. This method works for hardware, consumer, and marketplace startups where each milestone is binary and observable. It undervalues AI companies where a single patent portfolio exceeds the $2.5M cap.
2. The Scorecard Method
The Scorecard method (Bill Payne method) benchmarks your startup against the average pre-money valuation for similar companies in your region, then adjusts by weighted factors: team strength (0-30%), market size (0-25%), product and technology (0-15%), competitive environment (0-10%), marketing channels (0-10%), and need for additional investment (0-5%). For AI startups, the product and technology weight — specifically IP defensibility — swings valuations by 40% or more.
3. Risk-Factor Summation
Risk-Factor Summation starts with a base valuation (typically the regional average for pre-revenue deals) and adjusts +/- $250K for each of 12 risk factors: management, stage of business, legislation risk, manufacturing risk, sales and marketing risk, funding risk, competition, technology risk, litigation risk, international risk, reputation risk, and potential lucrative exit. Total adjustments move the final number by $3M in either direction.
4. The Venture Capital Method
The VC method works backwards from exit. Estimate the terminal value at exit (revenue multiplied by industry multiple), discount it by the investor's required return (typically 10-30x for pre-revenue), and divide by the post-money ownership target. A company with a projected $100M exit in 7 years, 20x return requirement, and $2M raise prices at $3M pre-money. This is the method most Series A investors run internally — and the one they will not tell you about unless you ask.
5. Cost-to-Duplicate
Cost-to-Duplicate calculates what it would cost to rebuild the startup from scratch: engineering salaries, R&D spend, patent filings, prototyping, regulatory approvals. It ignores future potential entirely and produces a floor value. Typical range for deep-tech: $1M-$8M. For AI startups, the number runs higher because training data acquisition, compute costs, and model development are steep and verifiable. For a deeper look at how each valuation approach applies beyond pre-revenue, see the five methods of valuation breakdown.
Which Pre-Revenue Startup Valuation Method Wins for AI Companies?
The Scorecard method wins for AI startups because it is the only pre-revenue startup valuation framework that explicitly weights IP defensibility — the factor that separates a $3M seed round from a $15M seed round in AI. No other method gives you a direct mechanism to score patents, proprietary data, and trade secrets as valuation inputs.
Hayat Amin's Pre-Revenue IP Scoring Model builds on the Scorecard method by replacing the generic "product/technology" weight with four IP-specific sub-scores: patent portfolio breadth (granted plus pending), proprietary data moat (exclusivity plus refresh rate), trade secret documentation maturity, and freedom-to-operate clearance. Beyond Elevation applies this model to every pre-revenue founder engagement.
The result: founders who score above 70% on IP defensibility close seed rounds at 2-3x the regional average valuation. The IP sub-scores give investors a concrete, auditable reason to pay more — not a pitch-deck promise, but documented defensibility they can verify in due diligence.
The VC method is a close second for AI companies, but only when the founder can credibly project a terminal value. For pre-revenue AI startups without comparable exits in their vertical, the Scorecard method is more reliable because it does not depend on speculative revenue forecasts. For AI-specific valuation frameworks, see how AI startups are actually valued.
How Does IP Change a Pre-Revenue Startup Valuation?
IP is the single largest valuation lever for pre-revenue startups because every method rewards risk reduction, and registered IP is the most verifiable form of risk reduction a company with no revenue can present. Patent filings shift the Scorecard by 15-40%. They move Risk-Factor Summation by $500K-$1.5M on the technology risk axis alone. They increase the VC method's terminal value because acquirers pay premium multiples for defensible companies.
Hayat Amin showed this in a recent engagement where a pre-revenue AI startup had three provisional patents covering its training pipeline architecture. Before the IP audit, the founders were preparing to raise at a $4M pre-money valuation — the regional average. After the Beyond Elevation team documented the patent portfolio's coverage, mapped it against competitors using the Scorecard method, and scored IP defensibility at 82%, the founders raised at $9.5M pre-money. Same team, same product, same market. The only variable that changed was the IP story investors could verify.
The pattern is consistent across engagements. Structured IP documentation adds 15-40% to Scorecard and Risk-Factor Summation outputs. A provisional patent costs $1,500-$3,000 to file. The valuation lift from that filing is 50-100x the cost. No other pre-revenue spend delivers that return.
What Mistakes Do Founders Make in Pre-Revenue Startup Valuation?
The most expensive mistake in pre-revenue startup valuation is using the wrong method for your company type. A deep-tech AI company valued using only Cost-to-Duplicate will price at $2-5M when the Scorecard method (properly weighted for IP) produces $8-15M. A consumer app valued using the VC method with aggressive exit projections will overprice and fail to raise entirely.
Hayat Amin reminds founders of three rules. First, never present a single number — present the range from at least two methods and explain why they agree or diverge. Investors respect founders who show their work. Second, never raise without filing. A provisional patent costs less than $3,000 and shifts the Scorecard by 15-25% — the highest-ROI spend in fundraising. Third, never let the investor pick the method. The investor's preferred method always produces the number that favours their ownership target. Show up knowing all five.
One more pattern: founders who wait until after the term sheet to file IP lose the defensibility signal entirely. The filing date matters. Pre-term-sheet filings tell investors the founder planned for defensibility. Post-term-sheet filings look reactive — and investors discount them accordingly.
How to Prepare for a Pre-Revenue Valuation Conversation
Preparation separates the founders who raise at $4M from those who raise at $10M on the same fundamentals. Hayat Amin's standard pre-raise checklist at Beyond Elevation includes five steps: file provisional patents on core innovations, document trade secrets with access controls and timestamps, run the Scorecard method yourself with honest weights, prepare a one-page IP defensibility summary for the data room, and rehearse the "here is how we valued ourselves" conversation with specific method outputs.
The founders who do this work command the negotiation. The founders who skip it accept whatever the investor offers — and that gap compounds across every future round. IP valuation for fundraising covers the full playbook for translating patent assets into investor-grade valuation inputs.
FAQ
How do you value a startup with no revenue?
Apply one or more of the five pre-revenue startup valuation methods: Berkus (milestone-based, up to $2.5M), Scorecard (weighted comparison to regional averages), Risk-Factor Summation (base value adjusted by 12 risk factors), Venture Capital Method (back-calculated from projected exit), or Cost-to-Duplicate (rebuild cost floor). For IP-heavy companies, the Scorecard method with IP-defensibility weighting produces the most accurate result.
What is the Berkus method of startup valuation?
The Berkus method assigns up to $500K for each of five risk-reduction milestones: sound idea, prototype, management team, strategic relationships, and product rollout. Maximum pre-money valuation is $2.5M. It works for early-stage hardware and consumer startups but undervalues AI companies where IP assets exceed the $2.5M cap.
Does IP increase a pre-revenue startup valuation?
Yes. Companies with patents are 10.2x more likely to secure early-stage funding. In the Scorecard method, strong IP defensibility adds 15-40% to the base valuation. Filing a provisional patent before the term sheet is the highest-ROI pre-fundraising investment a founder can make.
Which valuation method do VCs prefer for pre-revenue startups?
Most VCs run the Venture Capital method internally because it back-calculates from their required return. The Scorecard method is gaining ground for AI startups because it explicitly weights IP defensibility — the variable that most separates AI valuations from generic software valuations.
How much is a pre-revenue AI startup worth in 2026?
Pre-revenue AI startups with strong IP defensibility raise at $5M-$15M pre-money in 2026, compared to $2M-$5M for unprotected companies at the same stage. The premium is driven by patent portfolio breadth, proprietary data moats, and documented trade secret programs that reduce investor risk.